Trial intelligence / Profile preview

Comparison of Four Pulpotomy Techniques in Primary Molars

NCT03135626Phase 3Completed

Sponsor
Istanbul University
Start
Mar 2013
Primary completion
Jan 2014
Modality
Small Molecules, Device-based Delivery
01

Overview

Phase 3, randomised trial of Biodentine and mineral trioxide aggregate in dental caries (4 arms), sponsored by Istanbul University. Primary endpoint: Total success rate at 24 months. Started Mar 2013; status: completed.

02

Drugs

Biodentinemineral trioxide aggregate
03

Conditions

dental caries

Beyond the preview

Go deeper on NCT03135626.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03135626.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call